Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Dyax shares jump on drug study, FDA fast-track status
Dyax shares jump on drug study, FDA fast-track status
Dyax shares jump on drug study, FDA fast-track status
Submitted by
admin
on March 31, 2015 - 5:53pm
Source:
Marketwatch
News Tags:
Dyax
FDA
fast track
DX-2930
hereditary angiodema
Headline:
Dyax shares jump on drug study, FDA fast-track status
Do Not Allow Advertisers to Use My Personal information
